Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma
Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Erasmus MC, Amsterdam UMC Location Vrije Universiteit Amsterdam, Erasmus MC Cancer Institute, Amsterdam UMC Location University of Amsterdam, University Medical Center Groningen, Isala, St. Antonius Ziekenhuis, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, University Medical Center Utrecht
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, Onyx Pharmaceuticals
OpenAlex ID: W2120362266
